AbbVie Deutschland GmbH & Co. KG — China drug registrations and re-registration deadlines
9 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2027-02-04.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20170377 | OZURDEX 地塞米松玻璃体内植入剂 | 2027-08-04 | 2027-02-04 |
| 国药准字HJ20181115 | Aluvia 洛匹那韦利托那韦片 | 2027-11-15 | 2027-05-15 |
| 国药准字HJ20233125 | RINVOQ 乌帕替尼缓释片 | 2028-02-13 | 2027-08-13 |
| 国药准字SJ20191006 | HUMIRA 阿达木单抗注射液 | 2029-09-01 | 2029-03-01 |
| 国药准字SJ20215002 | HUMIRA 阿达木单抗注射液 | 2029-09-01 | 2029-03-01 |
| 国药准字SJ20200007 | HUMIRA 阿达木单抗注射液 | 2030-01-06 | 2029-07-06 |
| 国药准字HJ20150484 | Lumigan 贝美前列素滴眼液 | 2030-02-16 | 2029-08-16 |
| 国药准字SJ20260031 | EPKINLY 艾可瑞妥单抗注射液 | 2031-05-11 | 2030-11-11 |
| 国药准字SJ20260032 | EPKINLY 艾可瑞妥单抗注射液 | 2031-05-11 | 2030-11-11 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.